Henrik Sandvad Rasmussen
Net Worth

Last updated:

What is Henrik Sandvad Rasmussen net worth?

The estimated net worth of Dr. Henrik Sandvad Rasmussen is at least $4,908,559 as of 4 Jun 2021. He owns shares worth $32,433 as insider, has earned $1,355,846 from insider trading and has received compensation worth at least $3,520,280 in Allakos Inc..

What is the salary of Henrik Sandvad Rasmussen?

Dr. Henrik Sandvad Rasmussen salary is $880,070 per year as Strategic Advisor in Allakos Inc..

How old is Henrik Sandvad Rasmussen?

Dr. Henrik Sandvad Rasmussen is 66 years old, born in 1959.

What stocks does Henrik Sandvad Rasmussen currently own?

As insider, Dr. Henrik Sandvad Rasmussen owns shares in one company:

Company Title Shares Price per share Total value
Allakos Inc. (ALLK) Strategic Advisor 98,550 $0.33 $32,433

What does Allakos Inc. do?

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.

ALLK logo
ALLK
Allakos Inc.
$0.33

Henrik Sandvad Rasmussen insider trading

Allakos Inc.

Dr. Henrik Sandvad Rasmussen has made 7 insider trades in 2021, according to the Form 4 filled with the SEC. Most recently he sold 2,435 units of ALLK stock on 4 Jun 2021.

The largest trade he's ever made was exercising 21,952 units of ALLK stock on 3 Mar 2021. As of 4 Jun 2021 he still owns at least 98,550 units of ALLK stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 2,435 N/A N/A
Sale
Common Stock 10,000 $1.16 $11,630
Option
Stock Option (Right to buy) 10,000 $1.16 $11,630
Option
Common Stock 10,000 $1.16 $11,630
Sale
Common Stock 20,000 $1.16 $23,260
Option
Common Stock 20,000 $1.16 $23,260
Option
Stock Option (Right to buy) 20,000 $1.16 $23,260
Option
Common Stock 20,000 $1.16 $23,260
Option
Stock Option (Right to buy) 20,000 $1.16 $23,260
Sale
Common Stock 20,000 $1.16 $23,260
Option
Stock Option (Right to buy) 20,000 $1.16 $23,260
Option
Common Stock 20,000 N/A N/A
Sale
Common Stock 21,952 $57 $1,251,176
Sale
Common Stock 20,000 $1.16 $23,260
Option
Stock Option (Right to buy) 20,000 $1.16 $23,260
Option
Common Stock 20,000 N/A N/A
Option
Common Stock 20,000 $1.16 $23,260
Sale
Common Stock 20,000 $1.16 $23,260
Option
Stock Option (Right to buy) 20,000 $1.16 $23,260

Allakos key executives

Allakos Inc. executives and other stock owners filed with the SEC: